Back
Staar Surgical 10K Form
Buy
62
STAA
Staar Surgical
Last Price:
37.21
Seasonality Move:
3.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | STAA/Staar Surgical Quarterly |
2023-11-06 | 10Q | STAA/Staar Surgical Quarterly |
2023-08-02 | 10Q | STAA/Staar Surgical Quarterly |
2023-05-03 | 10Q | STAA/Staar Surgical Quarterly |
2022-11-02 | 10Q | STAA/Staar Surgical Quarterly |
2022-08-10 | 10Q | STAA/Staar Surgical Quarterly |
Receive STAA News And Ratings
See the #1 stock for the next 7 days that we like better than STAA
STAA Financial Statistics
Sales & Book Value
Annual Sales: | $322.42M |
---|---|
Cash Flow: | $-16.65M |
Price / Cash Flow: | 135.54 |
Annual Sales: | $8.32 |
Price / Book: | 4.48 |
Profitability
EPS (TTM): | 0.34000 |
---|---|
Net Income (TTM): | $16.61M |
Gross Margin: | $252.65M |
Return on Equity: | 4.33% |
Return on Assets: | 3.45% |
Staar Surgical Earnings Forecast
Key Staar Surgical Financial Ratios
- The Gross Profit Margin over the past 36 years for STAA is 78.36%.
- The Selling, General & Administrative Expenses for STAA have been equal to 55.88% of Gross Profit Margin.
- The Research & Development expenses have been 13.77% of Revenue.
- The Interest Expense is -5.14% of Operating Income.
- The Net Earning history of STAA is 6.62% of Total Revenues.
- Per Share Earnings over the last 36 years have been positive in 18 years.
Staar Surgical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | STAA |
CUSIP: | 852312 |
Website: | staar.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.8 |
Quick Ratio: | 5 |
Price-to-Earnings
Trailing P/E Ratio: | 86.58 |
---|---|
Forward P/E Ratio: | 43.04 |
STAA Technical Analysis vs Fundamental Analysis
Buy
62
Staar Surgical (STAA)
is a Buy
Is Staar Surgical a Buy or a Sell?
-
Staar Surgical stock is rated a Buy
The current Staar Surgical [STAA] share price is $37.23. The Score for STAA is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.